herbal preparation PC-CARE

Proprietary Blend 960mg, Reishi 4:1 Extract (Ganoderma Lucidum), Balkal Skullcap 4:1 Extract (Scutellaria Baicalens), Rabdosia Rubescens 5:1 Extract (leaf), Dyer's Woad 4:1 Extract (Isatis Indigotica) (leaf), Chrysanthemum 4:1 Extract (Dendranthema Morifolium), Saw Palmetto Berry Extract (Serenoa repens) (25 to), Secale Cereale Extract & Oil (Pollen Extract), Licorice Root Extract (Glycyrrhiza Glabra). Does Not Contain: Yeast, Wheat, Corn, Milk, Egg, Soy, Glutens, Artificial Colors or Flavors, Added Sugar, Starch, or Preservatives. Other Ingredients: Magnesium Stearate, Gelatin

Also Known As:

PC-CARE

Networked: 4 relevant articles (1 outcomes, 0 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1.	Athie, Alejandro: 1 article (01/2021)
2.	Boutros, Paul C: 1 article (01/2021)
3.	Cakir, Fatma Betul: 1 article (01/2021)
4.	Casanova-Salas, Irene: 1 article (01/2021)
5.	Del Re, Marzia: 1 article (01/2021)
6.	Kebudi, Rejin: 1 article (01/2021)
7.	Mateo, Joaquin: 1 article (01/2021)
8.	Miyamoto, David T: 1 article (01/2021)
9.	Pienta, Kenneth J: 1 article (01/2021)
10.	Posadas, Edwin M: 1 article (01/2021)

Related Diseases

1.	Prostatic Neoplasms (Prostate Cancer) 01/01/2020 - "Prostate cancer (PC) care is rapidly evolving, with improved treatment options and outcomes. " 01/01/2021 - "Genomic stratification can impact prostate cancer (PC) care through diagnostic, prognostic, and predictive biomarkers that aid in clinical decision-making. "
2.	Neoplasms (Cancer) 01/01/2021 - "PC is well developed in most high- -income countries; however in most low-income settings, where approximately 80% of patients with cancer requiring PC care for advanced disease live, PC services are still uncommon. "
3.	Death (Near-Death Experience) 06/01/2015 - "Controlling for NH hospice use, being in a NH with higher PC care knowledge scores was associated with residents having a higher likelihood of documented six-month prognoses and lower likelihoods of having feeding tubes, injections, restraints, suctioning, and end-of-life hospital and ER use. "

Related Drugs and Biologics

1.	Biomarkers (Surrogate Marker)

Related Therapies and Procedures

1.	Injections